Trinity Capital Inc. pledges $15 million in growth capital to Velentium, boosting medical device innovation

Trinity Capital Inc., a financial solutions provider for growth-centric companies, has pledged $15 million in growth capital to Velentium, an engineering firm known for its innovative medical device designs. Based in Houston, Velentium specializes in developing and manufacturing medical devices, particularly active implantable and wearable devices. The firm’s diverse expertise covers systems engineering, software, cybersecurity, mobile/cloud solutions, and automated test systems, enabling them to collaborate with global clients in crafting medical solutions that enhance lives.

Ryan Kaeding, Managing Director of Life Sciences at Trinity, expressed confidence in Velentium’s unique abilities to support medical device customers and drive product innovation. Trinity aims to accelerate Velentium’s growth, positioning the firm as a comprehensive hub for end-to-end medical device design, development, and contract manufacturing. Velentium recently relocated to a new 50,000 square feet headquarters in Houston, featuring class 7 cleanrooms to enhance manufacturing capabilities. The financial backing from Trinity is set to sustain Velentium’s expansion efforts and fortify its market presence.

Velentium’s CEO, Dan Purvis, shared enthusiasm about the partnership with Trinity as they strive to advance their business scale and continue improving the safety and user-friendliness of medical devices. Their joint mission aims to create a positive impact through customer collaborations, aligning with Velentium’s commitment to “Change Lives for a Better World.” Trinity Capital Inc. remains dedicated to offering specialized financial solutions to support the growth ambitions of companies like Velentium, setting the stage for further advancements in the medical device industry.